UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
[Column] Correct diagnosis leads to proper treatment
by Shin Eui-cheol
2020-09-02 13:10
[Column] How ongoing doctors’ strike is different from 20 years ago
by Park Jae-young Executive editor
2020-08-25 17:07
A Korean-American Doctor asks: Is Korea truly in 2020?
by Korea Biomedical Review
2020-08-14 17:27
[Column] Covid-19 accelerated digital healthcare -- not in Korea yet
by Choi Yoon Sup
2020-08-03 16:03
[Column] Give choice to opt-out Oriental medicine from health insurance coverage
by Park Jae-young Executive editor
2020-07-21 11:46
라인
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
by Lee Han-soo
2020-06-25 11:17
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
by Lee Han-soo
2020-06-08 16:54
[Column] 'New normal' of healthcare in post-corona era
by Choi Yoon Sup
2020-05-20 14:53
[Column] Globalization of ‘Korea Covid19 Strategy’ and Dr. Lee Jong-wook
by Choo Moo-jin
2020-05-19 15:51
[Column] Are we ready for COVID-19’s arrival at schools?
by Korea Biomedical Review
2020-03-20 18:21
라인
[Column] Temporary nod for telemedicine against COVID-19 too hasty
by Choi Yoon Sup
2020-03-17 11:01
[Column] Will ‘third wave’ of COVID-19 hit Korea?
by Yoo Jin-hong
2020-03-16 17:08
[Column ] Anthelmintics as potential anticancer drugs?
by Heo Dae-seog
2020-02-17 18:26
[Column] Meaning of competent AI doctor
by Choi Yoon Sup
2020-02-17 17:00
[Column] In dealing with new coronavirus, luck could run out
by Kang Yang-gu
2020-02-07 16:48
라인
[Column] New coronavirus spread behooves upgraded quarantine of nation
by Hong Sung-Tae
2020-02-06 18:20
[Column] Arduous march has begun to combat new coronavirus
by Yoo Jin-hong
2020-02-03 18:23
[Column] Navigating a changing healthcare landscape with focus on patient centricity
by Peter Soelkner
2019-12-19 12:10
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
by Lee Han-soo
2019-12-11 17:37
[Column] Korea should do better in diabetes management
by Park Tae-sun
2019-11-08 15:57
-
1
2
3
4
5
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top